JB Chem & Pharma

₹1825 17.1 | 0.9%

WEBSITE BSE:506943 NSE : J.B.CHEMICAL 27 Dec, 09:09

Market Cap ₹28387 Cr.

Stock P/E 51.4

P/B 9

Current Price ₹1825

Book Value ₹ 203

Face Value 1

52W High ₹2029

Dividend Yield 0.67%

52W Low ₹ 1474

Edit Ratio

JB Chem & Pharma Research see more...

JB Chemicals: Business Analysis

Overview Inc. Year: 1976Industry: Pharmaceuticals & Drugs

J. B. Chemicals & Pharmaceuticals Ltd is an pharmaceutical company. It is an incorporated, research-orientated organization, which is focused on imparting products both in India and International markets. The Company manufactures and markets a range of herbal remedies, pharmaceutical formulations, active pharmaceutical ingredient (APIs). The Company is engaged in manufacturing distinctiveness merchandise that comprises various pharmaceutical dosage forms like drugs, injectable (vials, ampoules, form fill seal), creams & ointments, lozenges, liquids and pills. The Company's brands include Rantac (anti-peptic ulcerant), Cilacar (calcium channel blocker), Nicardia (calcium channel blocker) and Metrogyl (amoebicides).

JB Chem & Pharma Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

JB Chem & Pharma Quarterly Results

#(Fig in Cr.)	Dec 2015	Mar 2016	Jun 2016	Sep 2016	Dec 2016	Mar 2017	Jun 2017	Sep 2017	Dec 2017	Mar 2018
Net Sales	278	303	314	301	276	306	284	347	305	318
Other Income	9	20	11	15	8	13	9	10	5	11
Total Income	287	323	325	316	284	319	293	357	310	330
Total Expenditure	213	247	245	241	231	259	253	274	246	279
Operating Profit	74	76	80	75	53	60	40	83	64	51
Interest	3	2	1	2	2	-0	1	1	1	1
Depreciation	10	10	11	11	11	12	14	14	14	13
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	61	63	68	62	40	47	25	68	49	37
Provision for Tax	14	13	18	16	4	5	5	16	15	15
Profit After Tax	47	51	50	45	36	42	20	52	34	22
Adjustments	-47	-51	-50	-45	-36	-42	-20	-52	-34	-22
Profit After Adjustments	0	0	0	0	0	0	0	0	0	0
Adjusted Earnings Per Share	2.8	3	2.9	2.7	2.1	2.5	1.2	3	2	1.3

JB Chem & Pharma Profit & Loss

#(Fig in Cr.)	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Net Sales	957	1061	1165	1199	1255	1501	1641	1892	2190	2884	3299	1254
Other Income	38	10	56	50	56	40	50	116	39	9	37	35
Total Income	994	1072	1221	1248	1311	1541	1690	2008	2229	2893	3336	1290
Total Expenditure	802	868	939	980	1073	1213	1272	1340	1681	2219	2422	1052
Operating Profit	192	203	281	268	238	329	418	668	548	673	914	238
Interest	6	7	10	5	3	5	3	7	5	34	41	4
Depreciation	27	38	40	46	56	55	65	67	71	112	135	55
Exceptional Income / Expenses	-65	0	0	0	0	0	-10	0	0	0	0	0
Profit Before Tax	94	159	231	217	179	269	340	594	471	527	738	179
Provision for Tax	26	46	51	44	51	87	71	147	110	138	195	51
Profit After Tax	68	114	179	173	128	182	268	447	361	389	543	128
Adjustments	0	0	0	0	0	0	0	0	0	0	0	-128
Profit After Adjustments	68	114	179	173	128	182	268	447	361	389	543	0
Adjusted Earnings Per Share	4	6.7	10.6	10.2	7.7	11.3	17.3	28.9	23.4	25.1	35	7.5

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	14%	20%	17%	13%
Operating Profit CAGR	36%	11%	23%	17%
PAT CAGR	40%	7%	24%	23%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	12%	30%	53%	34%
ROE Average	21%	19%	21%	16%
ROCE Average	25%	24%	26%	20%

JB Chem & Pharma Balance Sheet

#(Fig in Cr.)	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Shareholder's Funds	1048	1016	1223	1388	1453	1485	1445	1806	2104	2442	2886
Minority's Interest	0	0	0	0	0	0	0	0	0	0	0
Borrowings	0	0	0	0	0	0	0	0	0	383	24
Other Non-Current Liabilities	32	34	46	42	63	79	73	86	477	610	452
Total Current Liabilities	262	398	736	667	712	763	494	646	419	579	1235
Total Liabilities	1342	1449	2005	2097	2228	2327	2012	2539	2999	4015	4597
Fixed Assets	282	301	369	609	570	552	583	565	1204	1822	1925
Other Non-Current Assets	96	304	522	333	211	253	223	178	593	724	542
Total Current Assets	964	844	1113	1155	1447	1522	1206	1796	1202	1470	2130
Total Assets	1342	1449	2005	2097	2228	2327	2012	2539	2999	4015	4597

JB Chem & Pharma Cash Flow

#(Fig in Cr.)	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Opening Cash & Cash Equivalents	149	11	-14	4	-25	7	16	6	24	38	54
Cash Flow from Operating Activities	-12	143	171	178	116	193	272	335	147	629	789
Cash Flow from Investing Activities	-139	-122	-52	-42	-24	-28	24	-231	4	-956	-412
Cash Flow from Financing Activities	12	-23	-97	-165	-59	-156	-305	-87	-138	343	-374
Net Cash Inflow / Outflow	-138	-2	22	-30	32	9	-10	18	13	16	3
Closing Cash & Cash Equivalent	11	9	7	-25	7	16	6	24	38	54	56

JB Chem & Pharma Ratios

#	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Earnings Per Share (Rs)	4.04	6.7	10.56	10.2	7.66	11.35	17.35	28.93	23.36	25.13	35.01
CEPS(Rs)	5.64	8.91	12.95	12.92	11.01	14.76	21.56	33.28	27.97	32.37	43.73
DPS(Rs)	1.5	7	2.5	0.5	1	2.5	5.5	8.25	8.25	8.88	12.25
Book NAV/Share(Rs)	61.83	59.92	72.08	81.81	86.96	92.51	93.51	116.87	132.05	149.97	176.97
Core EBITDA Margin(%)	15.9	17.93	19.38	18.23	14.52	19.21	22.44	29.19	22.7	22.22	25.66
EBIT Margin(%)	10.31	15.4	20.69	18.5	14.54	18.24	20.89	31.76	21.25	18.76	22.78
Pre Tax Margin(%)	9.7	14.79	19.8	18.08	14.27	17.94	20.7	31.38	21.03	17.62	21.6
PAT Margin (%)	7.06	10.56	15.38	14.43	10.2	12.13	16.34	23.63	16.11	13	15.89
Cash Profit Margin (%)	9.86	14.05	18.85	18.29	14.66	15.78	20.31	27.19	19.29	16.74	19.85
ROA(%)	5.23	8.14	10.38	8.43	5.92	7.99	12.36	19.65	13.04	11.09	12.62
ROE(%)	6.65	11.01	16.01	13.25	9.01	12.39	18.3	27.5	18.77	17.83	21.45
ROCE(%)	9.09	14.65	19.13	15.65	12.5	18.3	22.96	36.33	24.04	22.02	25.13
Receivable days	83.37	84.22	80.55	80.81	82.25	72.99	71.64	69.29	72.64	63.54	61.31
Inventory Days	37.88	40.66	41.01	44.65	48.83	46.67	48.96	49.29	51.19	44.94	45.28
Payable days	67.27	64.43	50.83	57.41	67.55	71.98	84.4	92.13	88.41	73.57	91.06
PER(x)	15.89	14.94	11.8	17.02	20.19	15.85	14.65	21.67	33.72	39.22	47.11
Price/Book(x)	1.04	1.67	1.73	2.12	1.78	1.94	2.72	5.36	5.96	6.57	9.32
Dividend Yield(%)	2.34	7	2	0.29	0.65	1.39	2.16	1.32	1.05	0.9	0.74
EV/Net Sales(x)	1.22	1.69	1.96	2.49	2.07	1.93	2.41	5.12	5.55	5.45	7.84
EV/Core EBITDA(x)	6.1	8.82	8.1	11.14	10.9	8.79	9.45	14.5	22.21	23.35	28.31
Net Sales Growth(%)	17.16	10.97	9.75	2.9	4.7	19.62	9.3	15.31	15.74	31.7	14.37
EBIT Growth(%)	-11.56	65.89	45.39	-7.97	-17.73	50.09	25.15	75.33	-20.75	17.87	38.75
PAT Growth(%)	-19.44	65.99	57.77	-3.48	-26	42.23	47.28	66.73	-19.25	7.72	39.72
EPS Growth(%)	-19.46	65.84	57.75	-3.48	-24.89	48.14	52.91	66.73	-19.25	7.59	39.33
Debt/Equity(x)	0.09	0.1	0.14	0.04	0.02	0.02	0.02	0.01	0.01	0.23	0.12
Current Ratio(x)	3.69	2.12	1.51	1.73	2.03	1.99	2.44	2.78	2.87	2.54	1.72
Quick Ratio(x)	3.26	1.8	1.33	1.49	1.79	1.72	1.97	2.35	2.04	1.87	1.35
Interest Cover(x)	16.84	24.93	23.41	44.35	53.45	59.98	108.34	83.55	96.24	16.36	19.22
Total Debt/Mcap(x)	0.09	0.06	0.08	0.02	0.01	0.01	0.01	0	0	0.03	0.01

JB Chem & Pharma Shareholding Pattern

#	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Promoter	54	53.96	53.95	53.93	53.91	53.86	53.83	53.78	53.77	53.74
FII	8.85	8.66	8.8	8.63	9.54	10.05	10.35	11.05	12.17	13.61
DII	17.8	18.48	18.54	19.08	18.65	18.58	18.54	18.39	17.62	16.83
Public	19.35	18.91	18.71	18.36	17.91	17.51	17.28	16.78	16.43	15.82
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Promoter	4.17	4.17	4.17	4.17	4.17	8.35	8.35	8.35	8.35	8.35
FII	0.68	0.67	0.68	0.67	0.74	1.56	1.6	1.72	1.89	2.11
DII	1.38	1.43	1.43	1.48	1.44	2.88	2.87	2.85	2.74	2.61
Public	1.5	1.46	1.45	1.42	1.39	2.71	2.68	2.6	2.55	2.46
Others	0	0	0	0	0	0	0	0	0	0
Total	7.73	7.73	7.74	7.74	7.74	15.5	15.5	15.52	15.52	15.53

Pros

Company has delivered good profit growth of 24% CAGR over last 5 years
Company has reduced debt.
Company is almost debt free.

Cons

Debtor days have increased from 73.57 to 91.06days.
Stock is trading at 9 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

JB Chem & Pharma News

IPO

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

JB Chem & Pharma

Add Watchlist

JB Chem & Pharma Research see more...

Overview Inc. Year: 1976Industry: Pharmaceuticals & Drugs

JB Chem & Pharma Share Price

Alert Data

Quarterly Price

Peer Comparison

JB Chem & Pharma Quarterly Results

JB Chem & Pharma Profit & Loss

Growth Rates

JB Chem & Pharma Balance Sheet

JB Chem & Pharma Cash Flow

JB Chem & Pharma Ratios

JB Chem & Pharma Shareholding Pattern

JB Chem & Pharma News

IPO

Stocx: India's #1 Marketplace to Find Your Winning Stock

Please Login!

Error!